Nuvectis Pharma (NVCT)
(Delayed Data from NSDQ)
$6.00 USD
-0.17 (-2.76%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $5.98 -0.02 (-0.33%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth C Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Nuvectis Pharma, Inc. has a market cap of $157.07M, which represents its share price of $6.17 multiplied by its outstanding shares number of 25.46M. As a small-cap company, NVCT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NVCT 6.00 -0.17(-2.76%)
Will NVCT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVCT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVCT
Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect?
Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
NVCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nuvectis Pharma (NVCT) Is a Great Choice for 'Trend' Investors, Here's Why
Wall Street Analysts Predict a 169.94% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know
Other News for NVCT
Nuvectis Pharma Inc Reports Q2 2025 EPS of -$0. ...
Nuvectis Pharma GAAP EPS of -$0.30
Nuvectis Pharma (NVCT) Strengthens Position with Promising Trial Results
Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights | ...
Nuvectis Pharma reports Q2 EPS (30c) vs. (26c) last year